News Sernova Corp. Toronto S.E.

Equities

SVA

CA81732W1041

Market Closed - Toronto S.E. Other stock markets 03:59:59 2024-04-26 pm EDT			5-day change	1st Jan Change
0.44 ^CAD	+3.53%		-2.22%	-37.14%

Apr. 02	Sernova Corp. Provides Positive Clinical and Platform Portfolio Update	CI
Mar. 19	Sernova Corp. Reports Earnings Results for the First Quarter Ended January 31, 2024	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Sernova Provides Organizational Update	Apr. 25	AQ
Sernova Welcomes Dr. Bernd Muehlenweg as Evotec's Nominee for its Board of Directors	Apr. 22	AQ
Sernova Provides Positive Clinical and Platform Portfolio Update	Apr. 03	AQ
Sernova Corp. Provides Positive Clinical and Platform Portfolio Update	Apr. 02	CI
Sernova : INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS	Mar. 19	PU
Sernova Corp. Reports Earnings Results for the First Quarter Ended January 31, 2024	Mar. 18	CI
Sernova : Corporate Presentation March 2024	Mar. 15	PU
Sernova Corp. Announces CFO Changes	Mar. 11	CI
Sernova Announces Management Developments	Mar. 11	AQ
Sernova Corp. Reports Earnings Results for the Full Year Ended October 31, 2023	Jan. 29	CI
Sernova Provides Recap of 2023 Accomplishments and Anticipated 2024 Milestones	Jan. 29	AQ
Sernova Receives Orphan Drug and Rare Pediatric Disease Designations for its Hemophilia A Program from FDA	Nov. 27	MT
Sernova Receives Orphan Drug and Rare Pediatric Disease Designations for its Hemophilia A Program from FDA	Nov. 27	AQ
Sernova Announces New Advancements of Conformal Coating Technology in Combination with the Cell Pouch System at the 2023 IPITA-IXA-CTRMS Joint Congress	23-10-31	AQ
Sernova Announces Positive Ongoing Interim Phase 1/2 Clinical Data for the Cell Pouch System for Type 1 Diabetes Trial at the 2023 IPITA, IXA, and CTRMS Joint Congress	23-10-30	AQ
Sernova Announces New Advancements of Conformal Coating Technology in Combination with the Cell Pouch System™ at the 2023 IPITA-IXA-CTRMS Joint Congress	23-10-30	AQ
Sernova Corp. Announces New Advancements of Conformal Coating Technology in Combination with the Cell Pouch System? at the 2023 IPITA-IXA-CTRMS Joint Congress	23-10-30	CI
Sernova Announces Positive Interim Phase 1/2 Clinical Data for the Cell Pouch System for Type 1 Diabetes Trial	23-10-27	MT
Sernova Announces Positive Ongoing Interim Phase 1/2 Clinical Data for the Cell Pouch System™ for Type 1 Diabetes Trial at the 2023 IPITA, IXA, and CTRMS Joint Congress	23-10-27	AQ
Sernova Announces Positive Ongoing Interim Phase 1/2 Clinical Data for the Cell Pouch System? for Type 1 Diabetes Trial at the 2023 IPITA, IXA, and CTRMS Joint Congress	23-10-27	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Sernova Corp. Toronto S.E.

Equities

SVA

CA81732W1041

Summary

Filters